Inventory decreased 34.0%
Inventory changed -34.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed -34.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed -519 basis points from the comparable as-filed period.
Operating margin changed -1972 basis points from the comparable as-filed period.
Net income changed +88.7% from the comparable as-filed period.
Cash & equivalents changed +28.2% from the comparable as-filed period.
Operating income changed -110.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory / revenue changed -4793 basis points from the comparable as-filed period.
Gross profit changed -18.7% from the comparable as-filed period.
Revenue changed -4.5% from the comparable as-filed period.
Research & development changed +14.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.